Lancaster Timothy S, Schill Matthew R, Greenberg Jason W, Moon Marc R, Schuessler Richard B, Damiano Ralph J, Melby Spencer J
Division of Cardiothoracic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri.
Division of Cardiothoracic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St. Louis, Missouri.
Ann Thorac Surg. 2016 Oct;102(4):1181-8. doi: 10.1016/j.athoracsur.2016.06.066. Epub 2016 Sep 2.
Despite a lack of demonstrated efficacy, potassium and magnesium supplementation are commonly thought to prevent postoperative atrial fibrillation (POAF) after cardiac operation. Our aim was to evaluate the natural time course of electrolyte level changes after cardiac operation and their relation to POAF occurrence.
Data were reviewed from 2,041 adult patients without preoperative AF who underwent coronary artery bypass grafting, valve operation, or both between 2009 and 2013. In patients with POAF, the plasma potassium and magnesium levels nearest to the first AF onset time were compared with time-matched electrolyte levels in patients without AF.
POAF occurred in 752 patients (36.8%). At the time of AF onset or the matched time point, patients with POAF had higher potassium (4.30 versus 4.21 mmol/L, p < 0.001) and magnesium (2.33 versus 2.16 mg/dL, p < 0.001) levels than controls. A stepwise increase in AF risk occurred with increasing potassium or magnesium quintile (p < 0.001). On multivariate logistic regression analysis, magnesium level was an independent predictor of POAF (odds ratio 4.26, p < 0.001), in addition to age, Caucasian race, preoperative β-blocker use, valve operation, and postoperative pneumonia. Prophylactic potassium supplementation did not reduce the POAF rate (37% versus 37%, p = 0.813), whereas magnesium supplementation was associated with increased POAF (47% versus 36%, p = 0.005).
Higher serum potassium and magnesium levels were associated with increased risk of POAF after cardiac operation. Potassium supplementation was not protective against POAF, and magnesium supplementation was even associated with increased POAF risk. These findings help explain the poor efficacy of electrolyte supplementation in POAF prophylaxis.
尽管缺乏已证实的疗效,但人们普遍认为补充钾和镁可预防心脏手术后的术后房颤(POAF)。我们的目的是评估心脏手术后电解质水平变化的自然时间进程及其与POAF发生的关系。
回顾了2009年至2013年间接受冠状动脉搭桥术、瓣膜手术或两者皆有的2041例无术前房颤的成年患者的数据。在发生POAF的患者中,将首次房颤发作时间最接近的血浆钾和镁水平与无房颤患者的时间匹配电解质水平进行比较。
752例患者(36.8%)发生POAF。在房颤发作时或匹配时间点,发生POAF的患者的钾(4.30对4.21 mmol/L,p<0.001)和镁(2.33对2.16 mg/dL,p<0.001)水平高于对照组。随着钾或镁五分位数的增加,房颤风险呈逐步上升(p<0.001)。多因素逻辑回归分析显示,除年龄、白种人种族、术前使用β受体阻滞剂、瓣膜手术和术后肺炎外,镁水平是POAF的独立预测因素(比值比4.26,p<0.001)。预防性补充钾并未降低POAF发生率(37%对37%,p = 0.813),而补充镁与POAF发生率增加相关(47%对36%,p = 0.005)。
较高的血清钾和镁水平与心脏手术后POAF风险增加相关。补充钾对POAF无保护作用,补充镁甚至与POAF风险增加相关。这些发现有助于解释补充电解质预防POAF疗效不佳的原因。